dronabinol has been researched along with Colorectal Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Ami Shor, D; Gluck, N; Hochman, I; Scapa, E; Shibolet, O | 1 |
| Amin, S; Desai, D; Graziane, NM; Morris, DP; Raup-Konsavage, WM; Sepulveda, DE; Vrana, KE | 1 |
| Hwang, YN; Kim, KC; Kwon, IS; Kwon, TH; Na, HH; Park, JH; Park, JS | 1 |
| Brizzi, A; Cerretani, D; Collodel, G; Fiaschi, AI; Menchiari, A; Micheli, L; Moltoni, L; Moretti, E | 1 |
| Han, SS; Jung, Y; Kang, Y; Kim, JA; Ku, SK; Lee, YR; Noh, SK; Park, PH; Thapa, D | 1 |
| Greenhough, A; Paraskeva, C; Patsos, HA; Williams, AC | 1 |
| Moyer, MP; Robertson, DA; Ward, SG; Wright, KL | 1 |
7 other study(ies) available for dronabinol and Colorectal Cancer
| Article | Year |
|---|---|
The Cytotoxic Effect of Isolated Cannabinoid Extracts on Polypoid Colorectal Tissue.
Topics: Antineoplastic Agents; Cannabidiol; Cannabinoids; Cannabis; Colonic Polyps; Colorectal Neoplasms; Dronabinol; Humans; Plant Extracts | 2022 |
Efficient Synthesis for Altering Side Chain Length on Cannabinoid Molecules and Their Effects in Chemotherapy and Chemotherapeutic Induced Neuropathic Pain.
Topics: Animals; Cannabinoids; Cannabis; Colorectal Neoplasms; Dronabinol; Mice; Neuralgia | 2022 |
Cell death induction and intracellular vesicle formation in human colorectal cancer cells treated with Δ
Topics: Adenosine Triphosphate; Apoptosis; Cannabis; Colorectal Neoplasms; Dronabinol; Humans; Plant Extracts; PPAR gamma | 2023 |
Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83.
Topics: Adenocarcinoma; Apoptosis; Cannabidiol; Cannabinoids; Catalase; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dronabinol; Glutathione Peroxidase; Glutathione Reductase; HT29 Cells; Humans; Malondialdehyde; Oxidative Stress | 2020 |
Anti-tumor activity of the novel hexahydrocannabinol analog LYR-8 in Human colorectal tumor xenograft is mediated through the inhibition of Akt and hypoxia-inducible factor-1α activation.
Topics: Angiogenesis Inhibitors; Animals; Chickens; Chorioallantoic Membrane; Colorectal Neoplasms; Cyclooxygenase 2; Dronabinol; HT29 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Proto-Oncogene Proteins c-akt; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |
The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells.
Topics: bcl-Associated Death Protein; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Dronabinol; Gene Expression Regulation, Neoplastic; Humans; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinases; ras Proteins; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA Interference; RNA, Messenger; Signal Transduction | 2007 |
Long term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer.
Topics: Adenoma; Anti-Obesity Agents; Apoptosis; Carcinoma; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dronabinol; Drug Inverse Agonism; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2008 |